CGC Genetics / CGC Centro Genetica Clinica
Established in 1992, CGC Genetics has solidified its position as a prominent provider of specialized genetic tests and has evolved into one of Europe's primary clinical laboratories. With its headquarters in Porto, the company operates five specialized laboratory departments and has facilities in Spain and the U.S.A.
CGC Genetics has garnered a global reputation, receiving genetic testing samples from various institutions worldwide, including public and private hospitals, physician clinics, university medical centers, reference labs, and insurance companies. Offering a comprehensive range of more than 3,400 genetic tests spanning diverse medical disciplines, including prenatal screening and diagnosis, hematology, oncology, neurology, ophthalmology, cardiology, preventive medicine, common and rare diseases, and pharmacogenetics/clinical trials.
The company specializes in CGH array, NGS panels, and Clinical Exome analysis, conducted and interpreted by medical geneticists with extensive clinical integration. With over 3,000 entries in reference laboratory genetic databases, CGC Genetics serves as an international reference laboratory, being the exclusive diagnostics provider for certain diseases. Additionally, they have introduced patent-pending panels known as CGC Mutation Panels, renowned for their exceptional value in molecular diagnostics (www.cgcgenetics.com).
The most recent investment in CGC Genetics was a Private Equity Round in February 2014 led by Vallis Capital Partners.
Industries: Biotechnology, Health Care| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Private Equity Round | Unknown | 1 |
|
01 Feb 2014 |
No recent news or press coverage available for CGC Genetics / CGC Centro Genetica Clinica.
We care about your data, and we'd love to use cookies make your experience better.
